should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous manifestations of psoriatic disease need to be considered in treatment targets.

Psoriatic arthritis surgery could involve removing damaged tissue or bone or replacing a joint with severe damage. Learn more ...

Rashes are a common symptom ... of this condition must receive appropriate treatment. What is a person’s life expectancy with psoriatic arthritis? PsA does not usually affect life expectancy ...

And when she did, she was diagnosed with psoriatic arthritis ... may temporarily stop treatment with COSENTYX if you develop ...

Plaque psoriasis (PsO) and psoriatic arthritis (PsA) are lifelong conditions that can have a significant impact on those ...

When compared with other biologic therapies, patients with psoriasis receiving IL-23 inhibitors had a lower risk for inflammatory arthritis or psoriatic arthritis development.

Tremfya (guselkumab) is a prescription drug that’s used to treat certain inflammatory conditions, such as psoriatic arthritis ... only for UC at the start of treatment.) Tremfya contains ...

The global psoriatic arthritis (PsA) treatment market is poised for remarkable expansion, with an anticipated valuation of ...

Juvenile idiopathic arthritis symptoms may only affect certain joints. Some children have systemic reactions, such as rash.

The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

Rheumatic diseases make up a collection of arthritis subtypes, but also include fibromyalgia, Sjogren's syndrome, and more.